Cloaked nanoparticles 'trick' immune system

Drugs delivered: Inflammatory, cancer drugs
Innovation: Hidden drugs that bypass immune system
Research organization: Methodist Hospital Research Institute

Earlier this year, researchers at the Methodist Hospital Research Institute in Houston created nanoparticles that act like white blood cells. The reason they act that way: They're cloaked in the membranes of those very same cells.

By removing the membranes from human blood cells--with all the lipids and proteins included--the scientists were able to "trick" the immune system into accepting drug-carrying nanoparticles, called LeukoLike Vectors, hidden beneath the membranes.

And like other drug-delivering nanotech, the cloaked particles allow for a very specific targeting mechanism. These vehicles could deliver treatments for inflamed tissue as well as cancer drugs. And the scientists are working on a way to synthesize the membranes to make the drugs more widely available.

Cloaked nanoparticles 'trick' immune system
Read more on

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.